Enovis ENOV
NYSE ENOV
$18.63 -0.40 (-2.10%)
As of: Sep 10, 2026 · 10:54 AM EDT

Enovis (ENOV) Income from Continuing Operations (2010 - 2026)

Enovis' (ENOV) quarterly Income from Continuing Operations came in at -$1.0 million in Q3 2026, up 97.16% year-over-year from -$525466.5 in Q3 2025, and up 87.68% quarter-over-quarter from -$8.4 million in Q2 2026.

Analysis

Enovis (ENOV) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Income from Continuing Operations for 17 consecutive years, with -$1.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Income from Continuing Operations rose 97.16% year-over-year to -$1.0 million in Q3 2026; TTM through Jul 2026 was -$1.1 billion, a 32.56% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 42.82% from the prior year.
  • Income from Continuing Operations was -$1.0 million for Q3 2026 at Enovis, up from -$8.4 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at $120.7 million in Q3 2022 and troughed at -$703.6 million in Q4 2024.
  • A 5-year average of -$117.3 million and a median of -$35.0 million in 2024 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations surged 386.51% in 2022 and plunged 23034.35% in 2024, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at -$54.8 million in 2022, then jumped by 105.59% to $3.1 million in 2023, then sank by 23034.35% to -$703.6 million in 2024, then climbed by 26.27% to -$518.8 million in 2025, then jumped by 99.8% to -$1.0 million in 2026.
  • The last three Income from Continuing Operations figures came in at -$1.0 million (Q3 2026), -$8.4 million (Q2 2026), and -$518.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 181.92 Bn 176.31 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.64 Bn 122.42 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.92 Bn 109.10 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.39 Bn 101.91 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 64.88 Bn 64.34 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.92 Bn 45.66 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.24 Bn 31.79 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.12 Bn 30.18 Bn 830.00 Mn 249.10 Mn
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn 201.00 Mn
10 Enovis 1.08 Bn 1.06 Bn 359.25 Mn -1.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 -1.04 Mn
Apr 3, 2026 -8.41 Mn
Dec 31, 2025 -518.80 Mn
Oct 3, 2025 -570.87 Mn
Jul 4, 2025 -36.46 Mn
Apr 4, 2025 -55.58 Mn
Dec 31, 2024 -703.63 Mn
Sep 27, 2024 -33.51 Mn
Jun 28, 2024 -18.44 Mn
Mar 29, 2024 -71.84 Mn
Dec 31, 2023 3.07 Mn
Sep 29, 2023 -19.45 Mn
Jun 30, 2023 -14.61 Mn
Mar 31, 2023 -22.85 Mn
Dec 31, 2022 -54.84 Mn
Sep 30, 2022 -65.95 Mn
Jul 1, 2022 120.65 Mn
Apr 1, 2022 -38.10 Mn
Dec 31, 2021 -14.74 Mn
Oct 1, 2021 -13.53 Mn